Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2005
12/22/2005WO2005121073A1 Inhibitors of histone deacetylase
12/22/2005WO2005121069A1 Levodopa prodrugs, and compositions and uses thereof
12/22/2005WO2005120515A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005WO2005120477A2 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators
12/22/2005WO2005103041A9 Treatment of cns disorders using cns target modulators
12/22/2005WO2005061443A3 Benzoyl-substituted phenylalanine amides
12/22/2005WO2004106296A3 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282905 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
12/22/2005US20050282891 Parkinson's disease, depression, attention deficit disorder; schizophrenia, manic depression, cognitive impairment disorders, restless legs syndrome, periodic limb movement disorders, Huntington's disease, Tourette's syndrome, congestive heart failure, sustained release
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282872 Novel thyroid receptor ligands and method II
12/22/2005US20050282871 3-(3,5-Disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors
12/22/2005US20050282869 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith
12/22/2005US20050282862 Aromatic amides
12/22/2005US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/22/2005US20050282846 Compounds capable of activating cholinergic receptors
12/22/2005US20050282817 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; obesity
12/22/2005US20050282809 Heteroaryl-hydrazone compounds
12/22/2005US20050282787 Synthesis of tetracyclines and analogues thereof
12/22/2005US20050282707 Pyridinylisoxazoles and their use as herbicides
12/22/2005CA2569883A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
12/22/2005CA2568632A1 Levodopa prodrugs, and compositions and uses thereof
12/22/2005CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005CA2564499A1 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity
12/21/2005EP1607388A1 An improved manufacturing process for methylphenidate and intermediates thereof
12/21/2005EP1606261A1 Novel process for the preparation of roflumilast
12/21/2005EP1606260A1 Oxamide derivatives useful as raf-kinase inhibitors
12/21/2005EP1606237A1 2-(butyl-1-sulfonylamino)-n- 1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/21/2005EP0579819B1 Novel pyridone derivative having an affinity for the angiotensine ii receptor
12/21/2005CN1711257A Aryl sulfonamides
12/21/2005CN1711252A 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
12/21/2005CN1711245A Process for the preparation of 2-aminomethylpyridine derivative
12/21/2005CN1711244A Novel process for the preparation of 2-aminomethylpyridine derivative
12/21/2005CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
12/20/2005US6977266 Pyridone derivatives having affinity for cannabinoid 2-type receptor
12/20/2005CA2302412C Aminoalkylphenol derivatives and related compounds
12/20/2005CA2181569C Ep2-receptor agonists as agents for lowering intraocular pressure
12/20/2005CA2174127C Phenylsulfonyl ureas, processes for their preparation, and their use as herbicides and plant growth regulators
12/15/2005WO2005118606A1 Fluorine-substituted iridium complex and luminescent material made with the same
12/15/2005WO2005118545A1 Gas-phase oxidation of alkyl-substituted heterocyclic compounds
12/15/2005WO2005118544A2 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005118542A1 Glucagon receptor antagonists, preparation and therapeutic uses
12/15/2005WO2005118541A2 Heterocyclic compounds and their use as aldosterone synthase inhibitors
12/15/2005WO2005117904A2 Phosphonate analogs of hiv integrase inhibitor compounds
12/15/2005WO2005117883A1 Modulators of muscarinic receptors
12/15/2005WO2005117867A2 Monocyclic heterocycles as kinase inhibitors
12/15/2005US20050277681 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
12/15/2005US20050277680 tyrphostin-like compounds that display a significant potency as kinase inhibitors, cause the downregulation of c-myc proto-oncogene and inhibit the growth and survival of cancerous cell lines; antiproliferative agents
12/15/2005US20050277678 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent
12/15/2005US20050277667 Manufacturing process for methyl phenidate and intermediates thereof
12/15/2005US20050277663 3-Aryl-3-hydroxy-and 3-aryl-3-oxopropionic acid esters as fungicides
12/15/2005US20050277662 such as: 1-(2, 4-difluorobenzyl) -N-hydroxy-3-(morpholin-4-ylmethyl)-1H-pyrrolo[2,3-c]pyridine-5-carboxamide; acquired immunodeficiency syndrome ("AIDS"), and AIDS related complex ("ARC")
12/15/2005US20050277652 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
12/15/2005US20050277649 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors; potentiation; diabetes and obesity; 2-(4-{4-[1-(6-chloro-pyridin-3-yl)cyclopropylmethyl]-2-(R)-methyl-piperazine-1-sulfonyl}phenyl)-1,1,1-trifluoro-propan-2-ol
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277631 Vanilloid receptor ligands and their use in treatments
12/15/2005DE4332964B4 Verfahren zur Herstellung von aromatischen Polyetherketonen A process for the preparation of aromatic polyetherketones
12/15/2005DE102004024565A1 Verfahren zur Herstellung von α-Chloralkylpyridylketonen und/oder deren Hydrochloriden A process for preparing α-Chloralkylpyridylketonen and / or their hydrochlorides
12/15/2005CA2568524A1 Modulators of muscarinic receptors
12/15/2005CA2568164A1 Heterocyclic compounds and their use as aldosterone synthase inhibitors
12/15/2005CA2566531A1 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/15/2005CA2563831A1 Monocyclic heterocycles as kinase inhibitors
12/15/2005CA2562713A1 Phosphonate analogs of hiv integrase inhibitor compounds
12/14/2005EP1603923A1 Metal complexes
12/14/2005EP1603879A2 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
12/14/2005EP1603878A1 Processes for the preparation of n-heteroaryl-n-aryl-amines by reacting an n-aryl carbamic acid ester with a halo-heteroaryl and analogous processes
12/14/2005EP1603877A1 NOVEL AMINOPYRIDINE DERIVATIVES AS mGIuR5 ANTAGONISTS
12/14/2005EP1603876A1 Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto esters
12/14/2005EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use
12/14/2005EP1603572A1 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors
12/14/2005EP1603570A2 Aminoheteroaryl compounds as protein kinase inhibitors
12/14/2005EP1603562A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
12/14/2005EP1326858B1 Piperidine compounds as anti-allergic
12/14/2005EP1263712B1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
12/14/2005EP1224165B1 Novel compounds
12/14/2005EP1200411B1 Process for synthesis of heteroaryl-substituted urea compounds
12/14/2005CN1708482A N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
12/14/2005CN1708481A N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
12/14/2005CN1708478A P-(sulfonyl)-aryl and heteroaryls amines
12/14/2005CN1708476A Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
12/14/2005CN1231476C Substd. pyridine herbicides
12/14/2005CN1231465C Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
12/14/2005CN1231464C Novel 3-substituted urea derivatives and medicinal use thereof
12/14/2005CN1231440C Novel tricyclic compound
12/14/2005CN1231431C Process for preparing substituted 2-3-dihydro-1-indanones
12/14/2005CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
12/13/2005US6974876 Method for preparing intermediates useful in synthesis of retroviral protease inhibitors
12/13/2005US6974836 Diamines as modulators of chemokine receptor activity
12/13/2005US6974830 For therapy of atherosclerosis, gallstone disease, lipid disorders, obesity or a cardiovascular disorder
12/13/2005US6974828 3-((2-((3-((Amino(imino)methyl)amino)benzoyl)amino)phenyl)sulf anyl)- 3-(3-pyridinyl)propanoic acid, for example; angiogenic inhibitors; antitumor, -carcinogenic, -metastatic, -diabetic, -arthritic and inflammatory agents; bone disorders
12/13/2005US6974817 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP)
12/13/2005US6974802 Treatment of viral infections using prodrugs of 2′,3-dideoxy,3′-fluoroguanosine
12/13/2005US6974567 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
12/08/2005WO2005116198A2 Methods of 1,3-enyne preparation using copper (i) catalysts
12/08/2005WO2005116010A1 Ep4 receptor agonist, compositions and methods thereof
12/08/2005WO2005115992A1 Theramutein modulators
1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 633